| COMPANY |
Ginkgo Bioworks Holdings, Inc. (“Ginkgo”) (NYSE: DNA) f/k/a Soaring Eagle Acquisition Corp. |
| COURT |
United States District Court for the Northern District of California |
| CASE NUMBER |
21-cv-08943 |
| JUDGE |
Magistrate Judge Kandis A. Westmore |
| CLASS PERIOD |
May 11, 2021 and October 5, 2021 |
| SECURITY TYPE |
Common Stock |
Case Background:
A class action lawsuit has been filed on behalf of those who purchased or acquired Ginkgo Bioworks Holdings, Inc. (“Ginkgo”) (NYSE: DNA) f/k/a Soaring Eagle Acquisition Corp. (“Soaring Eagle”) (NASDAQ: SRNG) securities between May 11, 2021 and October 5, 2021, both dates inclusive (the “Class Period”).
The complaint alleges that throughout the Class Period, the Defendants failed to disclose that Ginkgo’s failure to derive real revenue from third-party customers left it almost completely dependent on related parties that Ginkgo created or controlled through its ownership and board seats.
Current Status of Case:
On April 10, 2024, Lead Plaintiff filed an Unopposed Motion for Preliminary Approval of Settlement. On July 31, 2024, the Court entered an Order granting the Lead Plaintiff’s Motion for Preliminary Approval of Settlement and scheduled a Final Approval Hearing on December 5, 2024.
The deadline to file a claim is November 21, 2024. If you have any questions or need further information about this settlement, you may go to the following website www.GinkgoSecuritiesSettlement.com, or you can contact the claims administrator, Strategic Claims Services, at 1-866-274-4004.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.